Recent studies how found evidence that Depo-Provera massively increases the risk of developing brain tumors even after women ...
At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which will take place in December 2026, ...
See more stories on Insider's business page. A third dose of Pfizer's coronavirus vaccine yields mild to moderate side effects, much like the second shot, according to data released this month by the ...
Pfizer’s battle over the safety label for its birth control injection has finally come to a close. The pharma giant announced that the Food and Drug Administration approved its new safety warning ...
Most people won't experience allergic reactions to the vaccine, experts insist. The Food and Drug Administration late Friday authorized Pfizer's COVID-19 vaccine for people ages 16 and up, but warned ...
(RTTNews) - Hospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection Carpuject Units, ...
ALBANY, N.Y. (NEWS10)- After months of anticipation, the Federal Food and Drug Administration (FDA) approved the use of Pfizer’s COVID-19 vaccine. On December 17 the FDA will vote to approve Moderna’s ...
(Reuters Breakingviews) - Pfizer has made more than its share of value-destroying acquisitions. The pharmaceutical giant's $15 billion purchase of Hospira could reverse that history. The ...
WASHINGTON -- The pharmaceutical giant Pfizer tightened its policies Friday regarding the use of drugs in lethal injections, a move experts said would make it harder for states to carry out executions ...
A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing ...
Every time Andrew publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...
Both vaccines are administered in two doses and have similar effective rates. After the second dose, Pfizer’s vaccine is 95% effective, Moderna’s 94.5% effective but there are many differences. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results